130 related articles for article (PubMed ID: 6423392)
1. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of the myeloma-associated membrane antigen KMA.
Goodnow CC; Raison RL
J Immunol; 1985 Aug; 135(2):1276-80. PubMed ID: 3925006
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agent.
Walker KZ; Boux HA; Hayden GE; Goodnow CC; Raison RL
Adv Exp Med Biol; 1985; 186():833-41. PubMed ID: 3931433
[TBL] [Abstract][Full Text] [Related]
4. A tumor-associated antigen specific for human kappa myeloma cells.
Boux HA; Raison RL; Walker KZ; Hayden GE; Basten A
J Exp Med; 1983 Nov; 158(5):1769-74. PubMed ID: 6195295
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of an epitope on human free kappa-light chains and on a cytoplasmic component in activated T cells.
Walker KZ; Hayden GE; Goodnow CC; Boux HA; Adams E; Basten A; Raison RL
J Immunol; 1985 Feb; 134(2):1059-64. PubMed ID: 2578149
[TBL] [Abstract][Full Text] [Related]
6. MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide.
Asvadi P; Cuddihy A; Dunn RD; Jiang V; Wong MX; Jones DR; Khong T; Spencer A
Br J Haematol; 2015 May; 169(3):333-43. PubMed ID: 25653020
[TBL] [Abstract][Full Text] [Related]
7. Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
Sieverts H; Alabaster O; Goldschmidts W; Magrath I
Cancer Res; 1986 Mar; 46(3):1182-8. PubMed ID: 3080238
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
[TBL] [Abstract][Full Text] [Related]
9. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
Hagner G
Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
[TBL] [Abstract][Full Text] [Related]
10. [The analysis of immunoregulation of idiotype synthesis by monoclonal anti-idiotypic antibody].
Fujisaku A
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):134-45. PubMed ID: 3084367
[TBL] [Abstract][Full Text] [Related]
11. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia.
Fukushima PI; Nguyen PK; O'Grady P; Stetler-Stevenson M
Cytometry; 1996 Dec; 26(4):243-52. PubMed ID: 8979022
[TBL] [Abstract][Full Text] [Related]
14. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
Pickering JW; Gelder FB
J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
[TBL] [Abstract][Full Text] [Related]
15. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
Babusíková O; Stevulová L
Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies.
Haegert DG
Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876
[TBL] [Abstract][Full Text] [Related]
17. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
19. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane associated free kappa light chains are found on a subset of tonsil and in vitro-derived plasmablasts.
Hutchinson AT; Jones DR; McCauley Winter P; Tangye SG; Raison RL
Hum Immunol; 2014 Sep; 75(9):986-90. PubMed ID: 25149546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
